DIABETIC FOOTWEAR MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America has emerged as the dominant region in the global diabetic footwear market. North America alone accounts for over 51.2% of the market share in 2024, due to rising the prevalence of diabetes and growing awareness about managing the disease. The presence of leading footwear brands, such as Dr. Comfort, Orthofeet, Aetrex, and Drew, has strengthened the distribution and supply chain network across the region. Moreover, several medical insurance policies in the U.S. provide coverage for custom-molded diabetic shoes, which has propelled the sales in the past decade.

Apart from having a large customer base of diabetic population, North America is also a key exporter of diabetic footwear to other developed markets. Leading manufacturers leverage free trade agreements to expand exports from the U.S. and Canada. They focus on European countries, Asia Pacific, and Middle Eastern markets that have high demand but limited local production. The pricing of diabetic shoes varies across different U.S. states, with average footwear cost ranging from USD 200 to USD 500 depending on customization and material used.

Asia Pacific has emerged as the fastest growing regional market for diabetic footwear. China accounts for the largest share within the region primarily due to rising geriatric population and growing prevalence of diabetes. The Chinese government has incorporated measures to educate people about diabetes management and foot care. This has boosted the adoption of specialty footwear for therapeutic purposes. India is another prominent market in Asia Pacific led by increasing health awareness, rapid urbanization, and large patient pool. Overall, the Asia Pacific market has high potential owing to unmet needs in diabetes management and an evolving retail landscape for specialty medical products.